Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q1 2019 Earnings

21FebConfirmed

Q2 2018

Q3 2018

Q4 2018

Q1 2019

-0.23

-0.16

-0.08

-0.01

Details

Expected EPS

-0.04

Actual EPS

-0.01

Surprise EPS

0.03

Surprise Percent

+75%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.01 per share for Q1 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.